Antibiotic Treatment of Haemophilus Influenzae and Haemophilus Parainfluenzae Infections in Patients with Cystic Fibrosis

During the period 1977–81, 188 Cystic fibrosis patients have been treated with 1254 anti‐haemophilus treatments in the Danish Cystic Fibrosis Center. On an average, each patient received 1.7 courses of chemotherapy per year. Haemophilus infections were more prevalent in the youngest age group of patients. The average number of H. influenzae precipitins increased with age, and this pattern was consistent throughout the whole study. The standard treatment was orally administered pivampicillin or amoxicillin given for 14 days. I case of allergy or ampiciUin‐resistant strains, erythromycin was given, in most cases alone, in some cases in combination with rifampicin. The overall results showed, that H. influenzae was eradicated from sputum by a single course of chemotherapy in 73 % of the courses and H. parainfluenzae in 100 % of the courses. Six per cent of the patients suffered from chronic H. influenzae infection in spite of repeated treatments. No decrease of treatment efficiency was found even after many repeated chemotherapy courses. The prevalence of patients habouring ampiciUin‐resistant H. influenzae increased in the beginning of the period (6 %‐20 %), but a slight fall was subsequently observed.

[1]  M. Hodson Cystic fibrosis in adolescents and adults. , 1983, The Practitioner.

[2]  N. HØiby,et al.  ANTIMICROBIAL CHEMOTHERAPY IN CYSTIC FIBROSIS PATIENTS , 1982 .

[3]  N. Høiby MICROBIOLOGY OF LUNG INFECTIONS IN CYSTIC FIBROSIS PATIENTS , 1982 .

[4]  N. Høiby,et al.  IMMUNE COMPLEX MEDIATED TISSUE DAMAGE IN THE LUNGS OF CYSTIC FIBROSIS PATIENTS WITH CHRONIC PSEUDOMONAS AERUGINOSA INFECTION , 1982 .

[5]  B. Beck,et al.  HOW TO EVALUATE CLINICAL PARAMETERS AT A GLANCE , 1982 .

[6]  M. Marks The pathogenesis and treatment of pulmonary infections in patients with cystic fibrosis. , 1981, The Journal of pediatrics.

[7]  S. Po Local humoral immunity and immune reactions in the lungs of patients with cystic fibrosis. , 1981 .

[8]  N. HØiby,et al.  Cross‐Reactions Between Haemophilus Influenzae and Nineteen Other Bacterial Species , 1979, Acta pathologica et microbiologica Scandinavica. Section B, Microbiology.

[9]  N. HØiby,et al.  HYPERGAMMAGLOBULINEMIC PURPURA IN CYSTIC FIBROSIS , 1978, Acta paediatrica Scandinavica.

[10]  R. Wise,et al.  A comparison of three rapid methods for the detection of beta-lactamase activity in Haemophilus influenzae. , 1977, Journal of clinical pathology.

[11]  J. Porter,et al.  Serum precipitins against respiratory tract pathogens in 522 "normal" children, and 48 cases of cystic fibrosis treated with cloxacillin. , 1976, Archives of disease in childhood.

[12]  A. Wiik,et al.  Antibacterial precipitins and autoantibodies in serum of patients with cystic fibrosis. , 1975, Scandinavian journal of respiratory diseases.

[13]  J. May The flora of the respiratory tract in chronic disease* , 1975 .

[14]  N. Høiby Epidemiological investigations of the respiratory tract bacteriology in patients with cystic fibrosis. , 2009, Acta pathologica et microbiologica Scandinavica. Section B: Microbiology and immunology.

[15]  J. Raeburn,et al.  The Patterns of Infection in Cystic Fibrosis , 1974, Scottish medical journal.

[16]  N. Høiby,et al.  Identification and quantitation of precipitins against Pseudomonas aeruginosa in patients with cystic fibrosis by means of crossed immunoelectrophoresis with intermediate gel. , 2009, Acta pathologica et microbiologica Scandinavica. Section B: Microbiology and immunology.

[17]  M. Mearns,et al.  Bacterial Flora of Respiratory Tract in Patients with Cystic Fibrosis, 1950-1971 , 1972, Archives of disease in childhood.

[18]  D. Thompson,et al.  Bacterial Infection in Cystic Fibrosis , 1972, Archives of disease in childhood.

[19]  M. Burns,et al.  BACTERIAL PRECIPITINS 1N SERUM OF PATIENTS WITH CYSTIC FIBROSIS , 1968 .

[20]  M. Burns,et al.  Bacterial precipitins in serum of patients with cystic fibrosis. , 1968, Lancet.